Aim: To evaluate the effectiveness of using dissolving xylitol chewable tablets versus xylitol chewing gum in geriatric bedridden patients in decreasing bacterial count in both saliva and interdental plaque as well as in increasing salivary pH. Materials and Methods: Overall, 98 patients were included in this randomized clinical trial and they were divided into two groups (n = 49). Group 1 (intervention group) received xylitol chewable tablets (Listerine Ready Tabs), and group 2 (Control group) received xylitol chewing gum (Trident Original). The primary outcome was salivary mutans streptococci count, and secondary outcomes were interdental plaque mutans streptococci count (both were assessed through plate culturing on MSBA media) and salivary pH (measured by a pH meter). All outcomes were assessed at baseline, after 5 min, and after 15 days. Friedmann test was used to show the effect of follow-up periods followed by a multiple comparison with Dunn Bonferroni correction. Mann-Whitney test was used to compare between tested groups for all examined variables. Result: Regarding MS count in both saliva and interdental plaque, there was a statistically significant difference between both groups at baseline and after 5 min; however, after 15 days, there was no statistically significant difference between both groups. Regarding salivary pH, there was no statistically significant difference at baseline and after 5 min between both groups; however, after 15 days, there was a statistically significant difference between both groups. Conclusion: Both xylitol dissolving chewable tablet and xylitol chewing gum have potent antibacterial effects and enhanced salivary pH in geriatric bedridden patients.